Compare Otsuka Holdings Co., Ltd. with Similar Stocks
Dashboard
1
Strong Long Term Fundamental Strength with a 15.36% CAGR growth in Operating Profits
- Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 27.59
- The company has been able to generate a Return on Capital Employed (avg) of 12.29% signifying high profitability per unit of total capital (equity and debt)
2
Positive results in Jun 26
3
With ROE of 12.89%, it has a very attractive valuation with a 1.81 Price to Book Value
4
Majority shareholders : FIIs
5
Market Beating performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
JPY 5,956,588 Million (Large Cap)
14.00
NA
0.00%
-0.14
12.89%
1.92
Revenue and Profits:
Net Sales:
702,048 Million
(Quarterly Results - Jun 2026)
Net Profit:
119,247 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.83%
0%
12.83%
6 Months
35.97%
0%
35.97%
1 Year
66.32%
0%
66.32%
2 Years
65.11%
0%
65.11%
3 Years
142.6%
0%
142.6%
4 Years
172.7%
0%
172.7%
5 Years
189.08%
0%
189.08%
Otsuka Holdings Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.12%
EBIT Growth (5y)
15.36%
EBIT to Interest (avg)
29.84
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.80
Tax Ratio
23.39%
Dividend Payout Ratio
20.44%
Pledged Shares
0
Institutional Holding
0.28%
ROCE (avg)
12.99%
ROE (avg)
10.53%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.81
EV to EBIT
12.64
EV to EBITDA
9.80
EV to Capital Employed
1.94
EV to Sales
2.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.32%
ROE (Latest)
12.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
No Trend
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 3 Foreign Institutions (0.27%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
702,048.00
597,926.00
17.41%
Operating Profit (PBDIT) excl Other Income
176,819.00
133,168.00
32.78%
Interest
2,715.00
9,732.00
-72.10%
Exceptional Items
-3,764.00
-438.00
-759.36%
Consolidate Net Profit
119,247.00
89,896.00
32.65%
Operating Profit Margin (Excl OI)
207.60%
175.90%
3.17%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 17.41% vs 1.44% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 32.65% vs 183.33% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,468,892.00
2,329,861.00
5.97%
Operating Profit (PBDIT) excl Other Income
528,601.00
504,830.00
4.71%
Interest
7,181.00
7,130.00
0.72%
Exceptional Items
-28,409.00
-124,666.00
77.21%
Consolidate Net Profit
366,216.00
347,271.00
5.46%
Operating Profit Margin (Excl OI)
167.10%
170.30%
-0.32%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 5.97% vs 15.42% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 5.46% vs 176.71% in Dec 2024
About Otsuka Holdings Co., Ltd. 
Otsuka Holdings Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






